FY2026 Earnings Estimate for Plexus Issued By Zacks Research

Plexus Corp. (NASDAQ:PLXSFree Report) – Analysts at Zacks Research decreased their FY2026 earnings estimates for shares of Plexus in a report issued on Monday, December 8th. Zacks Research analyst Team now expects that the technology company will post earnings per share of $6.38 for the year, down from their previous estimate of $6.39. The consensus estimate for Plexus’ current full-year earnings is $5.90 per share. Zacks Research also issued estimates for Plexus’ Q4 2026 earnings at $1.70 EPS, Q2 2027 earnings at $1.70 EPS and Q3 2027 earnings at $1.81 EPS.

PLXS has been the topic of a number of other reports. Williams Trading set a $165.00 target price on Plexus in a research report on Monday, September 22nd. Needham & Company LLC boosted their price objective on Plexus from $158.00 to $165.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Benchmark reaffirmed a “buy” rating and set a $165.00 price objective on shares of Plexus in a research note on Friday, October 24th. Wall Street Zen cut shares of Plexus from a “buy” rating to a “hold” rating in a report on Saturday, November 22nd. Finally, Sidoti downgraded shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 target price on the stock. in a research report on Friday, October 24th. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Plexus currently has an average rating of “Hold” and an average target price of $159.00.

Check Out Our Latest Report on Plexus

Plexus Price Performance

Shares of NASDAQ:PLXS opened at $159.91 on Thursday. The company has a market capitalization of $4.28 billion, a PE ratio of 25.54 and a beta of 0.81. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.77 and a current ratio of 1.58. The stock has a fifty day moving average of $145.18 and a 200-day moving average of $138.46. Plexus has a one year low of $103.43 and a one year high of $172.89.

Plexus (NASDAQ:PLXSGet Free Report) last released its earnings results on Wednesday, October 22nd. The technology company reported $2.14 EPS for the quarter, beating the consensus estimate of $1.84 by $0.30. The business had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.05 billion. Plexus had a net margin of 4.29% and a return on equity of 12.77%. The business’s quarterly revenue was up .7% on a year-over-year basis. During the same period in the prior year, the business earned $1.85 earnings per share. Plexus has set its Q1 2026 guidance at 1.660-1.810 EPS.

Insider Buying and Selling

In other news, Director Karen Marie Rapp sold 500 shares of the stock in a transaction that occurred on Friday, November 28th. The shares were sold at an average price of $143.47, for a total value of $71,735.00. Following the completion of the sale, the director directly owned 7,665 shares of the company’s stock, valued at $1,099,697.55. This represents a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Angelo Michael Ninivaggi, Jr. sold 1,347 shares of the business’s stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $144.93, for a total transaction of $195,220.71. Following the transaction, the chief accounting officer directly owned 21,544 shares in the company, valued at $3,122,371.92. The trade was a 5.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 13,172 shares of company stock worth $1,883,740 over the last ninety days. 1.76% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Plexus

Several hedge funds have recently bought and sold shares of the business. American Century Companies Inc. increased its position in Plexus by 44.2% in the 3rd quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock worth $159,722,000 after buying an additional 338,119 shares during the period. Fuller & Thaler Asset Management Inc. increased its position in Plexus by 120.4% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company’s stock worth $44,655,000 after acquiring an additional 190,360 shares during the period. Nuveen LLC bought a new position in Plexus during the first quarter worth $22,975,000. Millennium Management LLC raised its stake in Plexus by 85.1% during the 1st quarter. Millennium Management LLC now owns 228,116 shares of the technology company’s stock valued at $29,229,000 after purchasing an additional 104,904 shares during the last quarter. Finally, Balyasny Asset Management L.P. bought a new stake in Plexus in the 3rd quarter valued at $12,509,000. 94.45% of the stock is owned by institutional investors and hedge funds.

About Plexus

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Featured Stories

Earnings History and Estimates for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.